For research use only. Not for therapeutic Use.
Uliledlimab is a potent against CD73 humanizedized monoclonal antibody. Uliledlimab inhibits the conversion of extracellular adenosine monophosphate (AMP) to adenosine. Uliledlimab can be used in research of cancer[1].
| Catalog Number | I043211 |
| CAS Number | 2378407-27-1 |
| Purity | ≥95% |
